Clinical trials recruiting in Burton-on-Trent, United Kingdom

Phase breakdown

Conditions recruiting in Burton-on-Trent, United Kingdom

Recruiting trials in Burton-on-Trent, United Kingdom

• A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
  NCT05085028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
  NCT05774951 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
  NCT03150576 · Phase: Phase 2, Phase 3 · Ages: 16 Years to 70 Years · Sex: All (male and female)
• Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
  NCT02246634 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years and older · Sex: All (male and female)
• Surveillance of Pancreatic Health After Diabetes Diagnosis
  NCT06803771 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 84 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Burton-on-Trent, United Kingdom?

5 recruiting trials have at least one study site in Burton-on-Trent, United Kingdom.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.